tiprankstipranks
Inozyme initiated with an Outperform at Raymond James
PremiumThe FlyInozyme initiated with an Outperform at Raymond James
1M ago
Inozyme Pharma’s Q3 2024 Financial and Clinical Progress
Premium
Company Announcements
Inozyme Pharma’s Q3 2024 Financial and Clinical Progress
2M ago
Inozyme reports Q3 EPS (39c), consensus (44c)
Premium
The Fly
Inozyme reports Q3 EPS (39c), consensus (44c)
2M ago
Inozyme appoints Erik Harris to board of directors
PremiumThe FlyInozyme appoints Erik Harris to board of directors
3M ago
Inozyme presents new data at ASBMR 2024 annual meeting
Premium
The Fly
Inozyme presents new data at ASBMR 2024 annual meeting
4M ago
Inozyme initiated with a Buy at Stifel
Premium
The Fly
Inozyme initiated with a Buy at Stifel
4M ago
Inozyme announces publication of preclinical data on INZ-701
PremiumThe FlyInozyme announces publication of preclinical data on INZ-701
6M ago
Inozyme’s INZ-701 awarded Fast Track designation by FDA
Premium
The Fly
Inozyme’s INZ-701 awarded Fast Track designation by FDA
7M ago
Inozyme initiated with an Overweight at Wells Fargo
Premium
The Fly
Inozyme initiated with an Overweight at Wells Fargo
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100